Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

Category: NSV News

NSV News Portfolio News
New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million
March 9, 2021

New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million

New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, announces that its portfolio company Ventyx Biosciences raised $114 million from blue-chip investors to advance a diverse pipeline of immunology programs. Ventyx Biosciences combines assets from three formerly

Read More
New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence
January 12, 2021

New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence

New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, today announces the merger of its portfolio company, Achronix Semiconductor Corporation (“Achronix”), with ACE Convergence Acquisition Corp. NSV is a founding investor in Achronix. Highlights: Achronix is the

Read More
Cookie Policy Privacy Policy